BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7288656)

  • 21. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
    Wood JM
    Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
    Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha-methyl-p-tyrosine suppresses the insomnia following lesion of the raphe system].
    Jouvet M
    C R Seances Soc Biol Fil; 1971 Jun; 165(11):2128-31. PubMed ID: 4403709
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. 1. On the sleepwaking cycles.
    Laguzzi RF; Adrien J; Bourgoin S; Hamon M
    Brain Res; 1979 Jan; 160(3):445-59. PubMed ID: 217478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic and raphe serotonergic systems in ovulation control.
    Meyer DC
    Endocrinology; 1978 Oct; 103(4):1067-74. PubMed ID: 744131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential rotational behaviour after unilateral 5,7-dihydroxytryptamine induced lesions of the dorsal raphé nucleus [proceedings].
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Br J Pharmacol; 1979 Nov; 67(3):431P-432P. PubMed ID: 574043
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of brain serotoninergic systems in C57BL and BALBc mice during development.
    Daszuta A; Barrit MC; Faudon M; Gambarelli F
    J Physiol (Paris); 1981; 77(2-3):315-8. PubMed ID: 7288648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroxytryptamines as tools to study the neurobiology of serotonin.
    Baumgarten HG; Klemm HP; Sievers J; Schlossberger HG
    Brain Res Bull; 1982; 9(1-6):131-50. PubMed ID: 7172024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

  • 32. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent effects of 5,7-dihydroxytryptamine on serotonin transporter in different brain areas in the rat.
    Kostowski W; Bidziński A; Krzaścik P; Szyndler J; Rok P; Kołomańska P; Wisłowska A; Lehner M; Płaźnik A
    Pol J Pharmacol; 2004; 56(4):383-9. PubMed ID: 15520491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reengineering the brain serotonin system: localized application of specific neurotoxins and fetal serotonergic neurons into the adult CNS.
    Azmitia EC
    Adv Neurol; 1986; 43():493-507. PubMed ID: 3484856
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neonatal administration of 5,7-dihydroxytryptamine induces in the adult rat a decrease in paradoxical sleep restored by an intracisternal injection of fetal raphe cells].
    Glin L; Gandolfo G; McRae Degueurce A; Gottesmann C
    Rev Electroencephalogr Neurophysiol Clin; 1986 Oct; 16(3):273-82. PubMed ID: 3809692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raphe lesions and 5,7-dihydroxytryptamine induce grooming reflexes in adrenalectomized cats.
    Swenson RM; Randall W
    J Comp Physiol Psychol; 1980 Apr; 94(2):353-64. PubMed ID: 7365006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine.
    Björklund A; Baumgarten HG; Rensch A
    J Neurochem; 1975 Apr; 24(4):833-5. PubMed ID: 1123645
    [No Abstract]   [Full Text] [Related]  

  • 39. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5,7-dihydroxytryptamine on HRP retrograde transport from hippocampus to midbrain raphe nuclei in the rat.
    Zhou FC; Azmitia EC
    Brain Res Bull; 1983 Apr; 10(4):445-51. PubMed ID: 6860973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.